MorphoSys AG (MOR)
18.41
+0.05
(+0.27%)
USD |
NASDAQ |
May 31, 16:00
18.40
-0.01
(-0.05%)
After-Hours: 20:00
MorphoSys 30-Day Average Daily Volume: 452565.3 for May 31, 2024
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| May 31, 2024 | 452565.3 |
| May 30, 2024 | 470549.6 |
| May 29, 2024 | 483091.7 |
| May 28, 2024 | 498184.7 |
| May 24, 2024 | 518319.1 |
| May 23, 2024 | 535418.4 |
| May 22, 2024 | 536976.4 |
| May 21, 2024 | 545474.4 |
| May 20, 2024 | 553832.0 |
| May 17, 2024 | 557877.2 |
| May 16, 2024 | 552343.0 |
| May 15, 2024 | 543959.9 |
| May 14, 2024 | 556250.1 |
| May 13, 2024 | 553313.2 |
| May 10, 2024 | 540638.7 |
| May 09, 2024 | 543704.3 |
| May 08, 2024 | 546420.7 |
| May 07, 2024 | 546930.2 |
| May 06, 2024 | 541514.2 |
| May 03, 2024 | 568445.3 |
| May 02, 2024 | 559987.1 |
| May 01, 2024 | 543068.8 |
| April 30, 2024 | 538686.7 |
| April 29, 2024 | 502094.3 |
| April 26, 2024 | 363790.2 |
| Date | Value |
|---|---|
| April 25, 2024 | 365175.9 |
| April 24, 2024 | 374476.0 |
| April 23, 2024 | 382455.6 |
| April 22, 2024 | 387236.5 |
| April 19, 2024 | 389765.3 |
| April 18, 2024 | 394243.2 |
| April 17, 2024 | 388178.1 |
| April 16, 2024 | 382562.3 |
| April 15, 2024 | 369700.8 |
| April 12, 2024 | 360253.2 |
| April 11, 2024 | 348615.0 |
| April 10, 2024 | 355515.5 |
| April 09, 2024 | 351579.2 |
| April 08, 2024 | 354246.5 |
| April 05, 2024 | 366590.6 |
| April 04, 2024 | 373850.1 |
| April 03, 2024 | 366358.2 |
| April 02, 2024 | 383483.1 |
| April 01, 2024 | 422371.5 |
| March 28, 2024 | 503773.6 |
| March 27, 2024 | 529422.6 |
| March 26, 2024 | 551358.3 |
| March 25, 2024 | 588926.2 |
| March 22, 2024 | 680888.9 |
| March 21, 2024 | 743442.8 |
30-Day Average Daily Volume Range, Past 5 Years
26487.43
Minimum
May 18 2021
3.925M
Maximum
Feb 20 2024
251428.3
Average
97197.20
Median
Mar 03 2023
30-Day Average Daily Volume Benchmarks
| Novartis AG | 1.516M |
| Immatics NV | 575643.1 |
| Affimed NV | 71921.87 |
| InflaRx NV | 201423.2 |
| BioNTech SE | 798667.3 |